$NFRM announced that its partner, Globe Laboratories concluded that GLB333, the Company's Lead Therapeutic drug may have effect in the treatment of Lupus. Lupus complications are caused by over expression of certain cytokine (interleukins) according to several scientific reports. http://t.co/IOu6b9Q 04/06/11